LARGEST STUDY ON GENETIC RISK FOR TYPE 2 DIABETES

<p>The diabetes field has long classified the disorder into genetically distinct groups, including type 1 and type 2. However, new genetics research focused on a form of type 2 diabetes (T2D) that is becoming more common in adolescents suggests a more complicated picture. Researchers at the Broad Institute of MIT and Harvard, Boston Children's Hospital, and Harvard Medical School analyzed DNA from more than 3,000 T2D participants between 12 and 18-years-old and nearly 9,800 adult controls, more than three-quarters of whom were of African American or Hispanic ancestry. They found that youth-onset T2D is a genetically intermediate form of the disorder that lies on a spectrum between adult-onset T2D and rare forms of the disorder caused by a single gene. Adult-onset T2D is influenced by thousands of common genetic variants, whereas the rare genetic forms, known as monogenic diabetes, are caused by a single variant. Moreover, these individuals harbored more of these variants than people <br>with adult-onset T2D, suggesting that genetics has a larger role in causing youth-onset T2D than in the adult-onset form.The work also revealed that the specific mix of different types of variants a given individual carried correlated with their particular set of symptoms. For example, those with more common variants showed more symptoms of adult-onset T2D, such as high insulin levels. Disease-causing genetic variants are generally classified as common (appearing in more than 5 percent in the population), rare (less than 1 to 5 percent of population), or monogenic (which are able to cause disease on their own). Teasing apart the contributions of these different types of variants in youth-onset T2D risk requires genetic data from thousands of patients</p>

Publication Details

Journal
Zenodo (CERN European Organization for Nuclear Research)
Published
2025-03-06
DOI
https://doi.org/10.5281/zenodo.14981722
Primary Topic
Pancreatic function and diabetes
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

LARGEST STUDY ON GENETIC RISK FOR TYPE 2 DIABETES

Zenodo (CERN European Organization for Nuclear Research)
Pancreatic function and diabetes
article

LARGEST STUDY ON GENETIC RISK FOR TYPE 2 DIABETES

article en

Abstract

<p>The diabetes field has long classified the disorder into genetically distinct groups, including type 1 and type 2. However, new genetics research focused on a form of type 2 diabetes (T2D) that is becoming more common in adolescents suggests a more complicated picture. Researchers at the Broad Institute of MIT and Harvard, Boston Children's Hospital, and Harvard Medical School analyzed DNA from more than 3,000 T2D participants between 12 and 18-years-old and nearly 9,800 adult controls, more than three-quarters of whom were of African American or Hispanic ancestry. They found that youth-onset T2D is a genetically intermediate form of the disorder that lies on a spectrum between adult-onset T2D and rare forms of the disorder caused by a single gene. Adult-onset T2D is influenced by thousands of common genetic variants, whereas the rare genetic forms, known as monogenic diabetes, are caused by a single variant. Moreover, these individuals harbored more of these variants than people <br>with adult-onset T2D, suggesting that genetics has a larger role in causing youth-onset T2D than in the adult-onset form.The work also revealed that the specific mix of different types of variants a given individual carried correlated with their particular set of symptoms. For example, those with more common variants showed more symptoms of adult-onset T2D, such as high insulin levels. Disease-causing genetic variants are generally classified as common (appearing in more than 5 percent in the population), rare (less than 1 to 5 percent of population), or monogenic (which are able to cause disease on their own). Teasing apart the contributions of these different types of variants in youth-onset T2D risk requires genetic data from thousands of patients</p>

Zenodo (CERN European Organization for Nuclear Research)
Good health and well-being
Openalex Percentile: Top 38%
Pancreatic function and diabetes
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

LARGEST STUDY ON GENETIC RISK FOR TYPE 2 DIABETES · Zenodo (CERN European Organization for Nuclear Research) (2025) | TGRS Research Map | TGRS